Muller M, Gfeller D, Coukos G, Bassani-Sternberg M. ‘Hotspots’ of antigen presentation revealed by human leukocyte antigen ligandomi cs for neoantigen prioritization. Front Immunol. (2017) 8:1367. doi:10.3389/ﬁmmu.2017.01367 71. Bairoch A, Apweiler R. The SWISS-PROT protein sequence databa se and its supplement TrEMBL in 2000. Nucleic Acids Res. (2000) 28:45–8. doi:10.1093/nar/28.1.45 72. Bassani-SternbergM,BraunleinE,KlarR,EngleitnerT,Sinit cynP,Audehm S, et al. Direct identiﬁcation of clinically relevant neoepitopes prese nted on nativehumanmelanomatissuebymassspectrometry. NatCommun. (2016) 7:13404.doi:10.1038/ncomms13404 73. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, et al. GENCODE: the reference human genome annotation for The ENCODE project. Genome Res. (2012) 22:1760–74. doi:10.1101/gr.135350.111 74. Bobisse S, Genolet R, Roberti A, Tanyi JL, Racle J, Stevenson BJ, et al. Sensitiveandfrequentidentiﬁcationofhighavidityneo-epi topespeciﬁcCD8 (+) T cells in immunotherapy-naive ovarian cancer. Nat Commun. (2018) 9:1092.doi:10.1038/s41467-018-03301-0 75. TüreciÖ,VormehrM,DikenM,KreiterS,HuberC,SahinU.Targeti ngthe heterogeneityofcancerwithindividualizedneoepitopevaccin es.ClinCancer Res.(2016)22:1885–96.doi:10.1158/1078-0432.CCR-15-1509 Frontiers in Immunology | www.frontiersin.org 15 August 2019 | Volume 10 | Article 1832 Bassani-Sternberg et al. Personalized Vaccine for Pancreatic Cancer 76. Gonzalez-Perez A, Perez-Llamas C, Deu-Pons J, Tamborero D, Schroe der MP, Jene-Sanz A, et al. IntOGen-mutations identiﬁes cancer dri vers across tumortypes. NatMethods.